Targeting the Lung: Preclinical and Comparative Evaluation of Anticancer Aerosols in Dogs with Naturally Occurring Cancers

Comparative Oncology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Current Cancer Drug Targets (Impact Factor: 3.58). 09/2003; 3(4):265-73. DOI: 10.2174/1568009033481903
Source: PubMed

ABSTRACT Pet dogs with naturally occurring cancers offer a novel opportunity for the study of both cancer biology and therapy. The following review will provide the rationale for the use of these spontaneous cancer models in translational research, particularly in the development of anticancer aerosols. A summary of work involving pet dogs with primary and metastatic cancers to the lung and the investigation of therapeutic chemotherapy and cytokine immunotherapy aerosols will be presented.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Background: Resiniferatoxin is a potent capsaicin analog. Intrathecal administration leads to selective, prolonged opening of the transient receptor potential V1 ion channel, which is localized mainly to C-fiber primary afferent nociceptive sensory neurons. Following work in laboratory animals, the authors explored the use of intrathecal resiniferatoxin to control spontaneous bone cancer pain in companion (pet) dogs.
    Anesthesiology 10/2005; 103(5):1052-1059. DOI:10.1097/00000542-200511000-00020 · 6.17 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: In present study authors review all aspects of pulmonary drug delivery system; including need of drug delivery, different approaches for drug delivery and recent advancement in pulmonary drug delivery system. Review deals with drug targeting to pulmonary region for the treatment of various diseases such as chronic obstructive pulmonary disease, lung cancer, cystic fibrosis, tuberculosis, asthma, etc. All these disorders are difficult to be effectively cured through conventional modes of dosage system rather novel delivery systems have been developed which proved to be more site specific and less toxic. Apart from various formulations, different delivery devices such as metered dose inhalers (MDI), dry powder inhalers (DPI), nebulizers, aerosolizers, etc. have also improved drug targeting efficacy and reduced dose size in a more efficient manner. This review contains mainly the tabulated description of different categories of drugs and devices recently available in the market which makes it easily accessible for the researchers. Proteins, other biologicals and different marketed products are also successfully available to be delivered through pulmonary route for the better patient management. It can be concluded from whole study that different pulmonary delivery system possesses certain specificity for dosage formulations and serves as an important tool to deliver drugs to the target site.
    Current Drug Therapy 04/2011; 6(2):137-151. DOI:10.2174/157488511795304930
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: This study evaluated tyrosine kinase receptor (TKR) expression and activation in canine pulmonary adenocarcinoma (cpAC) biospecimens. As histological similarities exist between human and cpAC, we hypothesized that cpACs will have increased TKR mRNA and protein expression as well as TKR phosphorylation. The molecular profile of cpAC has not been well characterized making the selection of therapeutic targets that would potentially have relevant biological activity impossible. Therefore, the objectives of this study were to define TKR expression and their phosphorylation state in cpAC as well as to evaluate the tumors for the presence of potential epidermal growth factor receptor (EGFR) tyrosine kinase activating mutations in exons 18-21. Immunohistochemistry (IHC) for TKR expression was performed using a tissue microarray (TMA) constructed from twelve canine tumors and companion normal lung samples. Staining intensities of the IHC were quantified by a veterinary pathologist as well as by two different digitalized algorithm image analyses software programs. An antibody array was used to evaluate TKR phosphorylation of the tumor relative to the TKR phosphorylation of normal tissues with the resulting spot intensities quantified using array analysis software. Each EGFR exon PCR product from all of the tumors and non-affected lung tissues were sequenced using sequencing chemistry and the sequencing reactions were run on automated sequencer. Sequence alignments were made to the National Center for Biotechnology Information canine EGFR reference sequence. The pro-angiogenic growth factor receptor, PDGFRalpha, had increased cpAC tumor mRNA, protein expression and phosphorylation when compared to the normal lung tissue biospecimens. Similar to human pulmonary adenocarcinoma, significant increases in cpAC tumor mRNA expression and receptor phosphorylation of the anaplastic lymphoma kinase (ALK) tyrosine receptor were present when compared to the corresponding normal lung tissue. The EGFR mRNA, protein expression and phosphorylation were not increased compared to the normal lung and no activating mutations were identified in exons 18-21. Canine pulmonary adenocarcinoma TKRs are detected at both the mRNA and protein levels and are activated. Further investigation into the contribution of TKR activation in cpAC tumorigenesis is warranted.
    BMC Veterinary Research 01/2014; 10(1):19. DOI:10.1186/1746-6148-10-19 · 1.74 Impact Factor


Available from